Daily Trade News

Pfizer’s Paxlovid doesn’t stack up as well for those who are


  1. Pfizer’s Paxlovid doesn’t stack up as well for those who are vaccinated, new data show Endpoints News
  2. Pfizer stops enrollment in Covid antiviral trial in standard-risk population CNBC
  3. Pfizer’s Paxlovid study fails to answer key questions over benefit for broader populations STAT
  4. Pfizer’s Paxlovid Doesn’t Help Healthier Patients (PFE) Bloomberg
  5. Pfizer’s Covid pill found to be ineffective for healthier patients Hindustan Times



Read More: Pfizer’s Paxlovid doesn’t stack up as well for those who are